Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: Complete Statistical AnalysisIndependent statistical analysis of NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: primary endpoint results, effect estimate…
- NAFLDIndependent statistical analysis of Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NAFLDIndependent statistical analysis of Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NAFT-600Independent statistical analysis of Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAITREIndependent statistical analysis of Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Naloxone, Hypoglycemia and Exercise: Complete Statistical AnalysisIndependent statistical analysis of Naloxone, Hypoglycemia and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03149770).
- Nalrexone Facilitated Discontinuation of Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Nalrexone Facilitated Discontinuation of Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01895036).
- Naltrexone & SSRI in Alcoholics With Depression/PTSD: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone & SSRI in Alcoholics With Depression/PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00338962).
- Naltrexone for Impulse Control Disorders in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone for Impulse Control Disorders in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052831).
- Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NAMESIndependent statistical analysis of Northwestern University and Access Community Health Network Medication Education Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01578577).
- NAPIndependent statistical analysis of Neural-net Artificial Pancreas (NAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05876273).
- NAPEIndependent statistical analysis of Oatmeal Effect on N-acyl-phosphatidylethanolamines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03468179).
- Napping, Sleep, Cognitive Decline and Risk of Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03256539).
- Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: Complete Statistical AnalysisIndependent statistical analysis of Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03167541).
- NAPSIndependent statistical analysis of Nattokinase Atherothrombotic Prevention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080520).
- Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty: Complete Statistical AnalysisIndependent statistical analysis of Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03457116).
- NARLALIndependent statistical analysis of Navelbine And Radiotherapy in Locally Advanced Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887783).
- Narrative Visualization for Breast Cancer Survivors’ Physical Activity: Complete Statistical AnalysisIndependent statistical analysis of Narrative Visualization for Breast Cancer Survivors' Physical Activity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03612596).
- Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: Complete Statistical AnalysisIndependent statistical analysis of Nasal EPAP for Stroke Patients With Sleep Apnea: a Pilot Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: Complete Statistical AnalysisIndependent statistical analysis of Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02340299).
- Nasal Noninvasive NAVA in the Very Low Birth Weight Infant: Complete Statistical AnalysisIndependent statistical analysis of Nasal Noninvasive NAVA in the Very Low Birth Weight Infant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01785563).
- Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation: Complete Statistical AnalysisIndependent statistical analysis of Nasal Physiologic Reactivity of Nonallergic Rhinitics to Cold Air Provocation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00415493).
- Nasal Pillows vs. Nasal Masks at High CPAP Pressure: Complete Statistical AnalysisIndependent statistical analysis of Nasal Pillows vs. Nasal Masks at High CPAP Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01690923).
- Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: Complete Statistical AnalysisIndependent statistical analysis of Nasal Tea Tree Oil for the Prevention of Infections in PD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care: Complete Statistical AnalysisIndependent statistical analysis of Nasal Versus Oral Midazolam Sedation in Routine Pediatric Dental Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02679781).
- NASHIndependent statistical analysis of Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NASHIndependent statistical analysis of The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASH Fitness Intervention in Thrombosis Trial (NASHFit): Complete Statistical AnalysisIndependent statistical analysis of NASH Fitness Intervention in Thrombosis Trial (NASHFit): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03518294).
- NASH-CXIndependent statistical analysis of Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis: primary endpoint results,…
- Nashville – Hypertension Management Model: Complete Statistical AnalysisIndependent statistical analysis of Nashville - Hypertension Management Model: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04232124).
- Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: Complete Statistical AnalysisIndependent statistical analysis of Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASQIndependent statistical analysis of Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Natalizumab and Chronic Inflammation: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab and Chronic Inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05177718).
- Natalizumab High Titer Immunogenicity and Safety: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab High Titer Immunogenicity and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516893).
- Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: Complete Statistical AnalysisIndependent statistical analysis of National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- National Prevalence and Impact of Noninvasive Prenatal Testing: Complete Statistical AnalysisIndependent statistical analysis of National Prevalence and Impact of Noninvasive Prenatal Testing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02284399).
- National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics: Complete Statistical AnalysisIndependent statistical analysis of National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Natreon Healthy Skin Study – PrimaVie Supplement: Complete Statistical AnalysisIndependent statistical analysis of Natreon Healthy Skin Study - PrimaVie Supplement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02762032).
- Natriuretic Peptides – Predictors of In-hospital and Long-term Major Adverse Cardiac Events After Emergency Surgery?: Complete Statistical AnalysisIndependent statistical analysis of Natriuretic Peptides - Predictors of In-hospital and Long-term Major Adverse Cardiac Events After Emergency Surgery?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NATRONIndependent statistical analysis of A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Natural Killer (NK) Cell Transplantation for AML: Complete Statistical AnalysisIndependent statistical analysis of Natural Killer (NK) Cell Transplantation for AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187096).
- Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: Complete Statistical AnalysisIndependent statistical analysis of Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD): Complete Statistical AnalysisIndependent statistical analysis of Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD): primary endpoint results, effect estimate with confidence interval,…
- NAUDIndependent statistical analysis of Neurobiology of Alcohol and Nicotine Co-Addiction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03338933).
- NAUSICAIndependent statistical analysis of Novel Angioplasty Using Coronary Accessor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00815997).
- NautilusIndependent statistical analysis of A Study of Two Types of Absorbable Surgical Sutures in the Suturing of Thyroid Surgery Incision: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NAV4-04Independent statistical analysis of Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…